Since Jason returned home, he has been steadily improving, inching closer to his health baseline before his initial chemotherapy treatment. Despite grappling with fatigue, bone pain, and neuropathy (tingling in his feet and hands), Jason's progress is noticeable. Today, he visited the Anschutz Cancer Center to monitor his levels and determine if he was able to have his second infusion treatment. Happy to report, his bloodwork showed promising results, allowing him to proceed today with chemotherapy.

Jason's healthcare team has devised a new treatment plan to minimize the likelihood of hospitalization post-treatment. Today, he received a modified dose of the original AAVD (Chemotherapy Cocktail), extending the total number of treatments from 12 to 16. We are optimistic that Jason's body will respond well to this adjusted regimen, enabling us to continue our positive momentum in battling the cancer.

We remain profoundly grateful for the unwavering love and support from our friends and family, both near and far. Your kindness means the world to us. Thank you all sincerely for your continued support.